We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 355

News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • March 15 2012

The Food and Drug Administration publishes its annual report on the status of the postmarketing studies or clinical trials that drug and biologics firms holding approved drug and biological products are either required or have committed to conduct


Biotech secures $7.2 million for cancer research
  • Shook Hardy & Bacon LLP
  • Singapore, USA
  • March 21 2013

Clearbridge BioMedics, a Singapore-based company that develops medical devices for cancer research and diagnostics, has announced a new series B


PolyMedix expects to raise $25 million for antibiotic development
  • Shook Hardy & Bacon LLP
  • USA
  • March 21 2013

PolyMedix, Inc. stockholders have overwhelmingly approved a reverse stock split of the company's common stock at a ratio of up to fifty-for-one


House appropriators concerned about sequestration of FDA user fees
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2013

Food and Drug Administration (FDA) Commissioner Margaret Hamburg reportedly testified before a House Appropriations Subcommittee about the effects of


News Bytes - June 6, 2013
  • Shook Hardy & Bacon LLP
  • USA
  • June 6 2013

The U.S. Patent and Trademark Office creates the After Final Consideration Pilot Program 2.0 which modifies and extends a program designed to


CRS issues report on compounded drugs
  • Shook Hardy & Bacon LLP
  • USA
  • June 6 2013

The Congressional Research Service (CRS) has issued a report titled "Compounded Drugs" to address the risks and oversight issues raised by the


FDA seeks premarket notification for mobile medical application
  • Shook Hardy & Bacon LLP
  • USA
  • June 6 2013

The U.S. Food and Drug Administration (FDA) has informed an India-based company that it is expected to file a premarket notification as to its uChek


Genetic technologies settles infringement suit over non-DNA coding technology
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2013

Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms


Annual report reveals need for biotech shift in focus to demonstrate drug value
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2013

According to Ernst & Young's 27th annual biotechnology industry report, the global biotechnology industry has continued its recovery, but small and


News Bytes - May 2, 2013
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2013

The National Nanotechnology Coordination Office schedules a June 11-12, 2013, public workshop in Washington, D.C., "to obtain input from stakeholders